| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |

* Institut de Pharmacologie et de Toxicologie,
Université de Lausanne, Lausanne,
Switzerland.
Swiss Institute for Experimental Cancer Research, Epalinges,
Switzerland.
Correspondence to Dr. Edith Hummler, Institut de Pharmacologie et de Toxicologie, Rue du Bugnon 27, CH-1005 Lausanne, Switzerland. Phone: 41-21-692-5357; Fax: 41-21-692-5355; E-mail: ehummler{at}pop-server.unil.ch
Abstract. The amiloride-sensitive epithelial sodium channel is the
limiting step in salt absorption. In mice, this channel is composed of three
subunits (
,
, and
), which are encoded by different genes
(Scnn1a, Scnn1b, and Scnn1c, respectively). The functions of
these genes were recently investigated in transgenic (knockout) experiments,
and the absence of any subunit led to perinatal lethality. More defined
phenotypes have been obtained by introducing specific mutations or using
transgenic rescue experiments. In this report, these approaches are summarized
and a current gene-targeting strategy to obtain conditional inactivation of
the channel is illustrated. This latter approach will be indispensable for the
investigation of channel function in a wide variety of organ systems.
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673